- Home
- Publications
- Publication Search
- Publication Details
Title
Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 4, Pages e0122646
Publisher
Public Library of Science (PLoS)
Online
2015-04-18
DOI
10.1371/journal.pone.0122646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Atrial Fibrillation With Use of Oral and Intravenous Bisphosphonates
- (2014) Abhishek Sharma et al. AMERICAN JOURNAL OF CARDIOLOGY
- Risk of Serious Atrial Fibrillation and Stroke With Use of Bisphosphonates
- (2013) Abhishek Sharma et al. CHEST
- Atorvastatin, Etidronate, or Both in Patients at High Risk for Atherosclerotic Aortic Plaques
- (2013) Tetsuya Kawahara et al. CIRCULATION
- Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
- (2012) Fabrizio D'Ascenzo et al. ATHEROSCLEROSIS
- Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis
- (2012) Frederick Wolfe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
- (2012) J.-H. Kang et al. OSTEOPOROSIS INTERNATIONAL
- A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke
- (2012) J.-H. Kang et al. OSTEOPOROSIS INTERNATIONAL
- Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study)
- (2012) Koji Ikeda et al. European Journal of Preventive Cardiology
- Atrial fibrillation and bisphosphonate therapy
- (2011) Michael Pazianas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials
- (2011) E. Barrett-Connor et al. OSTEOPOROSIS INTERNATIONAL
- Impact of Bisphosphonates on the Risk of Atrial Fibrillation
- (2010) Patricia A. Howard et al. American Journal of Cardiovascular Drugs
- Effect of Alendronate on Vascular Calcification in CKD Stages 3 and 4: A Pilot Randomized Controlled Trial
- (2010) Nigel D. Toussaint et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis
- (2010) Ippei Kanazawa et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Bisphosphonate use in women and the risk of atrial fibrillation: A systematic review and meta-analysis
- (2010) Rohit Bhuriya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials
- (2010) E. M. Lewiecki et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Bisphosphonates and risk of atrial fibrillation: a meta-analysis
- (2010) Seo Young Kim et al. ARTHRITIS RESEARCH & THERAPY
- Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
- (2009) Anselm Mak et al. BMC MUSCULOSKELETAL DISORDERS
- Bisphosphonates and Atrial Fibrillation
- (2009) Yoon Kong Loke et al. DRUG SAFETY
- The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis
- (2009) Murat Celiloglu et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?
- (2008) P. Anagnostis et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started